4//SEC Filing
Eizen Joshua M 4
Accession 0001193125-26-006763
CIK 0001880438other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:12 PM ET
Size
7.3 KB
Accession
0001193125-26-006763
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Sale
Common Stock
2026-01-05$1.00/sh−17,923$17,948→ 159,430 total - Sale
Common Stock
2026-01-06$1.01/sh−6,931$7,014→ 152,499 total
Footnotes (3)
- [F1]Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2026.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.001 to $1.003 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Includes (a) 30,000 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024, (b) 60,000 RSUs which vest as follows: 25% of the RSUs vest on January 1, 2025, 50% of the RSUs vest on January 1, 2026, and 25% of the RSUs vest on July 1, 2026, (c) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024, and (d) 58,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001949621
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 8:12 PM ET
- Size
- 7.3 KB